Literature DB >> 6886003

Harderoporphyria: a variant hereditary coproporphyria.

Y Nordmann, B Grandchamp, H de Verneuil, L Phung, B Cartigny, G Fontaine.   

Abstract

Three siblings with intense jaundice and hemolytic anemia at birth were found to excrete a high level of coproporphyrin in their urine and feces; the pattern of fecal porphyrin excretion was atypical for hereditary coproporphyria because the major porphyrin was harderoporphyrin (greater than 60%; normal value is less than 20%). The lymphocyte coproporphyrinogen III oxidase activity of each patient was 10% of control values, which suggests a homozygous state. Both parents showed only mild abnormalities in porphyrin excretion and lymphocyte coproporphyrinogen III oxidase activity decreased to 50% of normal values, as is expected in heterozygous cases of hereditary coproporphyria. Kinetic parameters of coproporphyrinogen III oxidase from these patients were clearly modified, with a Michaelis constant 15-20-fold higher than normal values when using coproporphyrinogen or harderoporphyrinogen as substrates. Maximal velocity was half the normal value, and we also observed a marked sensitivity to thermal denaturation. The possibility that a mutation affecting the enzyme on the active center which is specifically involved in the second decarboxylation (from harderoporphyrinogen to protoporphyrinogen) was eliminated by experiments on rat liver that showed that coproporphyrinogen and harderoporphyrinogen were metabolized at the same active center. The pattern of porphyrin excretion and the coproporphyrinogen oxidase from the three patients exhibited abnormalities that were different from the abnormalities found in another recently described homozygous case of hereditary coproporphyria. We suggest naming this variant of coproporphyrinogen oxidase defect "harderoporphyria."

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886003      PMCID: PMC1129282          DOI: 10.1172/JCI111039

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Isolation, structure and synthesis of a tricarboxylic porphyrin from the harderian glands of the rat.

Authors:  G Y. Kennedy; A H. Jackson; G W. Kenner; C J. Suckling
Journal:  FEBS Lett       Date:  1970-01-15       Impact factor: 4.124

2.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

3.  Decreased lymphocyte coproporphyrinogen III oxidase activity in hereditary coproporphyria.

Authors:  B Grandchamp; Y Nordmann
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

Review 4.  Pathogenesis and treatment of photocutaneous manifestations of the porphyrias.

Authors:  M B Poh-Fitzpatrick
Journal:  Semin Liver Dis       Date:  1982-05       Impact factor: 6.115

Review 5.  Enzymatic defects in porphyria: an overview.

Authors:  G H Elder
Journal:  Semin Liver Dis       Date:  1982-05       Impact factor: 6.115

Review 6.  Genetic, metabolic, and biochemical aspects of the porphyrias.

Authors:  S Sassa; A Kappas
Journal:  Adv Hum Genet       Date:  1981

7.  Homozygous case of hereditary coproporphyria.

Authors:  B Grandchamp; N Phung; Y Nordmann
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

8.  Familial and sporadic porphyria cutanea: two different diseases.

Authors:  H de Verneuil; G Aitken; Y Nordmann
Journal:  Hum Genet       Date:  1978-10-31       Impact factor: 4.132

9.  A radiochemical method for the measurement of coproporphyrinogen oxidase and the utilization of substrates other than coproporphyrinogen III by the enzyme from rat liver.

Authors:  G H Elder; J O Evans
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

10.  Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria.

Authors:  B Grandchamp; J C Deybach; M Grelier; H de Verneuil; Y Nordmann
Journal:  Biochim Biophys Acta       Date:  1980-05-22
View more
  18 in total

1.  Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria.

Authors:  J Lamoril; H Puy; S D Whatley; C Martin; J R Woolf; V Da Silva; J C Deybach; G H Elder
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

2.  Coexistent hereditary coproporphyria and congenital erythropoietic porphyria (Günther disease).

Authors:  Y Nordmann; D Amram; J C Deybach; L N Phung; D Lesbros
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

4.  The cyanobacterial protoporphyrinogen oxidase HemJ is a new b-type heme protein functionally coupled with coproporphyrinogen III oxidase.

Authors:  Petra Skotnicová; Roman Sobotka; Mark Shepherd; Jan Hájek; Pavel Hrouzek; Martin Tichý
Journal:  J Biol Chem       Date:  2018-06-20       Impact factor: 5.157

5.  Neonatal-Onset Hereditary Coproporphyria: A New Variant of Hereditary Coproporphyria.

Authors:  Kosei Hasegawa; Hiroyuki Tanaka; Miho Yamashita; Yousuke Higuchi; Takayuki Miyai; Junko Yoshimoto; Ayumi Okada; Norihiro Suzuki; Keiji Iwatsuki; Hirokazu Tsukahara
Journal:  JIMD Rep       Date:  2017-03-28

6.  Homozygous variegate porphyria: two similar cases in unrelated families.

Authors:  G M Murphy; J L Hawk; I A Magnus; D F Barrett; G H Elder; S G Smith
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

Review 7.  Hepatic porphyria: A narrative review.

Authors:  Sumant Arora; Steven Young; Sudha Kodali; Ashwani K Singal
Journal:  Indian J Gastroenterol       Date:  2016-10-31

8.  Role of aspartate 400, arginine 262, and arginine 401 in the catalytic mechanism of human coproporphyrinogen oxidase.

Authors:  Jason R Stephenson; Julie A Stacey; Justin B Morgenthaler; Jon A Friesen; Timothy D Lash; Marjorie A Jones
Journal:  Protein Sci       Date:  2007-01-22       Impact factor: 6.725

Review 9.  Molecular abnormalities of coproporphyrinogen oxidase in patients with hereditary coproporphyria.

Authors:  B Grandchamp; J Lamoril; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

10.  Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.

Authors:  H de Verneuil; C Beaumont; J C Deybach; Y Nordmann; Z Sfar; R Kastally
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.